Alnylam Pharmaceuticals
ALNY
#1096
Rank
ยฃ15.91 B
Marketcap
ยฃ118.81
Share price
1.20%
Change (1 day)
-64.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company